Melbourne, June 30, 2008 (ABN Newswire) - Mesoblast Limited’s (ASX:MSB; USOTC:MBLTY) “Off the Shelf” adult stem cells heal bodies without rejection or ethical issues, now about 3 years from commercialisation and trading near its lows.
Melbourne, June 30, 2008 (ABN Newswire) - Mesoblast Limited’s (ASX:MSB; USOTC:MBLTY) “Off the Shelf” adult stem cells heal bodies without rejection or ethical issues, now about 3 years from commercialisation and trading near its lows.
